Literature DB >> 1654890

Dolichol biosynthesis in human malignant cells.

A Henry1, P W Stacpoole, C M Allen.   

Abstract

Cholesterol, ubiquinone and dolichol biosynthesis from mevalonic acid was measured in non-malignant and malignant cultured human lymphocytes, freshly isolated human mononuclear leucocytes and in cultured human hepatoma cells. The relative flux of mevalonate into ubiquinone, dilichol and cholesterol was not significantly different between malignant and non-malignant cells, although the extent of labelling of each product was an order of magnitude greater in the malignant cultured cells. The most prominent dolichol isolated from total cellular lipid and synthesized in short-term labelling of cultured leukaemic cells had a chain length one isoprene unit shorter than that observed in normal human cells. Cultured human hepatoma cells and mononuclear leucocytes isolated from the peripheral blood of individuals with lymphoblastic and myelogenic leukaemia similarly synthesized shorter-chain dolichols. The dolichols made in cultured non-tumorigenic cells, freshly isolated mononuclear leucocytes from a normal individual or a patient with non-haematological malignancy had normal chain length.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1654890      PMCID: PMC1151409          DOI: 10.1042/bj2780741

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

Review 1.  Distribution, metabolism and function of dolichol and polyprenols.

Authors:  J W Rip; C A Rupar; K Ravi; K K Carroll
Journal:  Prog Lipid Res       Date:  1985       Impact factor: 16.195

2.  Identification and regulation of a rat liver cDNA encoding farnesyl pyrophosphate synthetase.

Authors:  M N Ashby; P A Edwards
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

3.  Regulation of cholesterol biosynthesis at a stage after the 3-hydroxy-3-methylglutaryl-CoA reductase step, in normal and leukemic (L2C) guinea pig lymphocytes.

Authors:  C Tabacik; S Aliau; J Sainte-Marie
Journal:  Biochim Biophys Acta       Date:  1987-09-25

4.  Characterization of the Saccharomyces cerevisiae cis-prenyltransferase required for dolichyl phosphate biosynthesis.

Authors:  W L Adair; N Cafmeyer
Journal:  Arch Biochem Biophys       Date:  1987-12       Impact factor: 4.013

5.  Possible involvement of 3-hydroxymethylglutaryl-CoA reductase in determining the side-chain length of ubiquinone in rat heart.

Authors:  S Shimizu; T Yamamoto; H Sugawara; Y Kawahara; K Momose
Journal:  Arch Biochem Biophys       Date:  1991-01       Impact factor: 4.013

6.  The mechanism and regulation of dolichyl phosphate biosynthesis in rat liver.

Authors:  R K Keller
Journal:  J Biol Chem       Date:  1986-09-15       Impact factor: 5.157

7.  Cytidine 5'-triphosphate-dependent dolichol kinase and dolichol phosphatase activities and levels of dolichyl phosphate in microsomal fractions from highly differentiated human hepatomas.

Authors:  I Eggens; J Ericsson; O Tollbom
Journal:  Cancer Res       Date:  1988-06-15       Impact factor: 12.701

8.  The influence of prolonged di(2-ethylhexyl)phthalate treatment on the dolichol and dolichyl-P content of rat liver.

Authors:  C Edlund; A E Ganning; G Dallner
Journal:  Chem Biol Interact       Date:  1986-03       Impact factor: 5.192

9.  Cholesterol synthesis and HMG CoA reductase activity during hepatocarcinogenesis in rats.

Authors:  R G Gregg; M Davidson; P A Wilce
Journal:  Int J Biochem       Date:  1986

10.  Dolichol and dolichyl phosphate in human tissues.

Authors:  O Tollbom; G Dallner
Journal:  Br J Exp Pathol       Date:  1986-10
View more
  1 in total

1.  Metabolomics profiling reveals new aspects of dolichol biosynthesis in Plasmodium falciparum.

Authors:  Flavia M Zimbres; Ana Lisa Valenciano; Emilio F Merino; Anat Florentin; Nicole R Holderman; Guijuan He; Katarzyna Gawarecka; Karolina Skorupinska-Tudek; Maria L Fernández-Murga; Ewa Swiezewska; Xiaofeng Wang; Vasant Muralidharan; Maria Belen Cassera
Journal:  Sci Rep       Date:  2020-08-06       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.